Drug Pricing EO Likely To Boost Telehealth-Pharma Partnerships

By Cara Smith / June 6, 2025 at 5:18 PM

President Donald Trump’s “most favored nation” executive order on drug pricing may jump start direct-to-consumer arrangements between pharmaceutical companies and telehealth providers, according to regulatory experts, similar to a deal GLP-1 maker Novo Nordisk recently penned with Hims & Hers and Ro.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.